RecruitingNCT07782684

Reconstruction Kinetics of γδ T Cells After Unrelated Cord Blood Transplantation

Reconstruction Kinetics of γδ T Cells and Their Clinical Impact After Unrelated Cord Blood Transplantation

Sponsor

Anhui Provincial Hospital

Enrollment

100 participants

Start Date

Oct 9, 2025

Study Type

OBSERVATIONAL

Conditions

Hematologic Disease and Disorders

Summary

The primary objective is to investigate the correlation between specific patterns of γδ T cell reconstitution after umbilical cord blood transplantation and key clinical outcomes.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders for people with hematologic disease and disorders. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREUmbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders

Allogeneic umbilical cord blood transplantation as a standard treatment for underlying hematological diseases.

Locations(1)

the First Affiliated Hospital of University of Science and Technology of China

Hefei, Anhui, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07782684

Related Trials

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

NCT0707518510 locations

CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research

NCT073130591 location

Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide

NCT068287961 location